Ceruloplasmin level in women with breast disease. Preliminary results.

Abstract

The average ceruloplasmin levels of 29 patients with active breast cancer and 22 patients in remission were 824 +/- 61 mg/l and 630 +/- 18 mg/l respectively. The average ceruloplasmin level of 17 patients with benign breast diseases was 555 +/- 29 mg/l and of 18 healthy women in a control group 584 +/- 17 mg/l. Breast cancer patients not in remission had ceruloplasmin levels which were significantly increased when compared to the other 3 groups. The CA 15-3 levels and ceruloplasmin levels were positively correlated. We propose that ceruloplasmin may be used as a tumour marker in the follow-up of patients with breast cancer.

• Authors: O Ozyilkan, E Baltali, E Ozyilkan, G Tekuzman, A Kars, D Firat
• Journal: Acta oncologica (Stockholm, Sweden) (Acta Oncol) Vol. 31 Issue 8 Pg. 843-6 ( 1992) ISSN: 0284-186X [Print] England
• PMID: 1290632 (Publication Type: Journal Article)

Chemical References

• Antigens, Tumor-Associated, Carbohydrate
• Biomarkers, Tumor
• Ceruloplasmin

Topics

• Adult
• Antigens, Tumor-Associated, Carbohydrate (blood)
• Biomarkers, Tumor (blood)
• Breast Neoplasms (blood)
• Ceruloplasmin (analysis)
• Female
• Humans
• Middle Aged